Pediatric Neurogenetics and Genomic Medicine
This track focuses on the role of genetic and genomic factors in pediatric neurological diseases, including chromosomal disorders, single-gene mutations, mitochondrial diseases, and complex polygenic conditions. It explores advancements in next-generation sequencing, whole-exome and whole-genome analysis, gene mapping, and molecular diagnostics that are transforming disease identification. The session highlights precision medicine approaches, gene therapy, RNA-based therapeutics, and CRISPR-based technologies. Emphasis is placed on early diagnosis of rare neurological disorders, genotype-phenotype correlations, and personalized treatment strategies for improved clinical outcomes.
Related Conference of Pediatric Neurogenetics and Genomic Medicine
June 22-23, 2026
18th Global Neurologists Meeting on Neurology and Neurosurgery
Amsterdam, Netherlands
June 29-30, 2026
31st International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences
Paris, France
July 20-21, 2026
11th International Conference on Central Nervous System Disorders & Therapeutics
Amsterdam, Netherlands
July 23-24, 2026
14th International Conference on Cannabis & Medicinal Research
Amsterdam, Netherlands
September 17-18, 2026
31st Global Experts Meeting on Neuroscience and Neuropharmacology
Paris, France
April 27-28, 2027
18th International Conference on Stroke, Neurology and Cerebrovascular Diseases
Paris, France